The Motley Foolยท2025-05-18 09:47Group 1: Applied Digital - Applied Digital has a market cap of approximately $1.3 billion and a share price below $6, with significant growth potential due to rising demand for data centers and cloud infrastructure [3][4] - The stock has increased nearly 60% over the past year but remains about 50% below its peak in February 2025, indicating potential for price recovery [4] - The company operates multiple data centers in North Dakota and other states, and plans to sell its cloud services business to fund investments in AI and high-performance computing [5][6] Group 2: IonQ - IonQ is a leader in quantum computing technology, with a current market cap around $8.2 billion and a share price just over $33, targeting a total addressable market of $87 billion by 2035 [7][8] - The company offers the Forte Enterprise system, which is the only quantum hardware available on major cloud platforms, showcasing its competitive advantage [8][9] - IonQ has secured partnerships with major companies, including SK Telecom, Toyota Tsusho, General Dynamics, and Nvidia, highlighting its industry relevance [10] Group 3: Summit Therapeutics - Summit Therapeutics has a market cap of roughly $17.2 billion and is focused on developing ivonescimab, an immunotherapy for non-small cell lung cancer, with results expected in mid-2025 [11][12] - The company has a strong chance of U.S. approval for ivonescimab, supported by its partner Akeso's previous successes in China [13] - Summit is also exploring ivonescimab for other cancer types, indicating substantial growth potential if the drug meets expectations [14]